First Time Loading...

Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 17.92 CNY -0.67% Market Closed
Updated: May 23, 2024
Shanghai Pharmaceuticals Holding Co Ltd
/
Income Statement
/
Interest Income Expense

Shanghai Pharmaceuticals Holding Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Pharmaceuticals Holding Co Ltd
Interest Income Expense Peer Comparison

Comparables:
1099
600998
C
600511
000963
C
000028

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Interest Income Expense
-¥1.1B
CAGR 3-Years
-79%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Sinopharm Group Co Ltd
HKEX:1099
Interest Income Expense
-¥3.1B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-8%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Interest Income Expense
-¥1.2B
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
-14%
C
China National Medicines Corp Ltd
SSE:600511
Interest Income Expense
¥526.1m
CAGR 3-Years
25%
CAGR 5-Years
26%
CAGR 10-Years
23%
Huadong Medicine Co Ltd
SZSE:000963
Interest Income Expense
-¥248.5m
CAGR 3-Years
-46%
CAGR 5-Years
-23%
CAGR 10-Years
-20%
C
China National Accord Medicines Corp Ltd
SZSE:000028
Interest Income Expense
¥27.4m
CAGR 3-Years
-47%
CAGR 5-Years
-33%
CAGR 10-Years
N/A

See Also

What is Shanghai Pharmaceuticals Holding Co Ltd's Interest Income Expense?
Interest Income Expense
-1.1B CNY

Based on the financial report for Mar 31, 2024, Shanghai Pharmaceuticals Holding Co Ltd's Interest Income Expense amounts to -1.1B CNY.

What is Shanghai Pharmaceuticals Holding Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-14%

Over the last year, the Interest Income Expense growth was -130%. The average annual Interest Income Expense growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been -79% over the past three years , -14% over the past five years .

ALPHA SPREAD
Join more than 140,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.